You are here: Industry Insights > API

News List

Thermogelling nanoemulsion enhances drug loading of hydrophobic APIs europeanpharmaceuticalreview
June 09, 2021
Using a new formulation technique, researchers were able to more than double drug loading of a hydrophobic active pharmaceutical ingredient in tablets. Thus, the new formulation method may lead to smaller pills delivering the same therapeutic benefit.
Onyx Scientific Receives Commercial API License for UK Facility contractpharma
June 04, 2021
Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility.
Biovectra Inc. Unveils New Logo and Brand contractpharma
June 04, 2021
?Biovectra Inc., a global contract development and manufacturing organization, has launched a new logo and brand to align with the growing company’s full suite of expertise and core values.
Sandoz outlines European antibiotic manufacturing expansion cphi-online
May 20, 2021
Novartis generics and biosimilars division will invest €150 million during the next 3-5 years at its Kundl, Austria and Palafolls, Spain sites while phasing out production of oral APIs at Les Franqueses site
Colorcon Adds New Containment Suite in Its Global Headquarters contractpharma
May 20, 2021
?Colorcon, a leader in the development and supply of film coating systems and excipients, has expanded its technical service capabilities with a new Containment Suite located in its Global Headquarters in Harleysville, PA, USA.
CMOs should invest in biologic API manufacturing capabilities, says GlobalData europeanpharmaceuticalreview
May 14, 2021
Research shows the complexity and number of biologics is increasing, as is the frequency at which their active pharmaceutical ingredient (API) production is outsourced.
Applying Agile methodologies in CDMOs expresspharma
May 14, 2021
In order to truly help biotech and pharma companies in their journey from drug development to commercialisation, contract development and manufacturing organisations (CDMOs) have begun to incorporate the latest innovations in all aspects of their ...
Growing opportunities in API manufacturing as innovative biologic approvals increase: GlobalData expresspharma
May 13, 2021
The US Food and Drug Administration (FDA) approved more biologic new molecular entities (NMEs) in 2020 than in any other year in the previous decade, while at the same time, sponsors increased the outsourcing of these biologics’ active pharmaceutical ...
Angelini Fine Chemicals Invests in Flow Chemistry & Micro-Reaction Technology contractpharma
May 13, 2021
A confluence of factors is driving the need for a paradigm shift in pharmaceutical manufacturing strategies in order to accelerate R&D pipeline to market.
Carbogen Amcis signs co-funding pact worth over CHF 15 million to expand Swiss site expresspharma
April 30, 2021
Carbogen Amcis will produce exclusively for the signatory customer a complex highly potent drug component for a commercial antibody-drug-conjugate API.